1. Introduction to Communicable Illnesses:
Communicable illnesses are conditions caused by microorganisms, like bacteria, viruses, fungi or parasites. These illnesses can be transmitted either directly or indirectly from person to person or from animals to humans. Over the course of history, they have played a role in causing sickness and death shaping human communities and societies. From outbreaks today global health crises these illnesses continue to present major challenges for public health.
The impact of illnesses goes beyond well-being affecting, economies, healthcare systems and social frameworks. Some notable examples include the flu, tuberculosis, HIV/AIDS and COVID 19. The ability to accurately and quickly detect these infections is crucial for treatment curbing transmission rates and managing outbreaks. Lessens the global impact of these infectious illnesses.
2.Traditional Methods of Detecting Infections:
Culture based techniques have been widely used to identify infectious agents, especially bacteria and fungi. This method involves taking a sample from the patient like blood, urine or tissue and trying to cultivate the pathogen in a lab using growth substances.
The process usually starts with introducing the sample onto culture mediums. These mediums are formulated to create conditions for the growth of microorganisms. For example, blood agar is often used for pathogens while Sabouraud dextrose agar is preferred for fungi. The cultures are then kept in controlled environments for incubation typically lasting 24 to 72 hours or more based on the suspected pathogen.
If growth is observed microbiologists can analyse colony characteristics conduct gram staining tests and perform assays to determine the organism’s identity. This technique does not confirm the presence of pathogens but also facilitates antimicrobial susceptibility testing essential for guiding treatment choices.
Despite its benefits culture-based detection has its drawbacks. It can be time consuming as it may take days or even weeks to detect growing organisms, like Mycobacterium tuberculosis. Additionally, some pathogens prove challenging or impossible to cultivate under lab conditions. This approach also relies on staff, properly outfitted facilities which might not be accessible in every situation.
3. Serological Testing; Detection of Antibodies and Antigens:
Serological tests play a role, in identifying diseases by recognizing either antibodies created by the immune system as a response to an infection or antigens from the pathogen itself. These are tests that detect antibodies aim to find antibodies in a patient’s blood or other bodily fluids. These antibodies are generated by the system when fighting an infection. Typically, two main types of antibodies are assessed: IgM, indicating an ongoing infection and IgG suggesting infection or immunity. The enzyme linked immunosorbent assay (ELISA) is a used technique for antibody detection. In many laboratories a commercially purchased ELISA kit that contains all the components to perform the assay is purchased. This ensures that the results can be obtained quickly as the ELISA test has already been optimised under strict QA/QC conditions.
Serological tests are often quicker than culture-based methods, with some rapid tests delivering results within minutes. Additionally, they can detect infections that may be challenging to culture. Yet they do have their restrictions, antibody tests might not work well in the stages of an infection before antibodies are produced. There is a possibility of results, due to cross reactivity with pathogens and missing positive cases could happen because of weakened immune response or the timing of the test in relation, to when the infection started.
4. Molecular Testing; Polymerase Chain Reaction (PCR) and DNA Sequencing:
The use of testing has transformed how infectious diseases are identified. These techniques directly spot the material of pathogens providing sensitive results. Two main technologies, in this field include Polymerase Chain Reaction (PCR) and DNA sequencing.
PCR is a method that amplifies DNA sequences allowing for the detection of small amounts of pathogen genetic material in a sample. Real time PCR, also called PCR (qPCR) enables real time quantification of the target DNA. It is commonly used to detect viruses, bacteria and other pathogens delivering results quicker than culture-based methods.
DNA sequencing takes diagnostics to the level by determining the precise sequence of nucleotides in a DNA sample. Generation sequencing (NGS) technologies have streamlined the process of sequencing pathogen genomes rapidly and affordably. Molecular techniques offer benefits such, as sensitivity and specificity detection of non-culturable or slow growing organisms and simultaneous identification of multiple pathogens using multiplex assays.
They are quicker, than the culture techniques. However, they need tools and skilled staff which may restrict their use in places, with resources. Furthermore, although these methods can identify the material of pathogens, they may not always signal the existence of contagious organisms.
5. Rapid Testing; at Point of Care (POCT):
Rapid point of care tests (POCTs) has become assets in diagnosing diseases providing swift results directly at the patient’s location. These tests are user friendly requiring training and equipment making them suitable for environments such as clinics, emergency rooms, field hospitals and locations with limited resources.
Some rely on flow immunoassays to identify antigens or antibodies to home pregnancy tests. Others may use techniques like amplification to detect pathogen genetic material without the need for complex thermal cycling equipment typically used in traditional PCR.
POCTs deliver results within minutes enabling quick clinical decision making. This speed is crucial in managing diseases, by facilitating initiation of treatment and infection control measures. Additionally, POCTs are generally more cost effective than laboratory-based tests. Do not require infrastructure making them accessible across various settings.
However, POCTs also come with limitations. They might have limited sensitivity compared to laboratory-based tests missing cases, with minimal levels of pathogens or antibodies. Certain point of care tests offer /negative outcomes instead of precise measurements, which might not provide as much insight, in specific medical situations. However, the significance of point of care tests in managing diseases is increasing, in situations where quick outcomes are vital or when access, to a traditional laboratory is restricted.
6. Imaging Methods; for Diagnosing Diseases:
Although not the primary tool for diagnosing infectious diseases various imaging methods play a vital role in identifying and tracking infections especially those impacting internal organs or deep tissues. These techniques offer insights into the location, severity and progression of infections supplementing diagnostic methods.
- X rays are commonly used, for infections. Chest X rays can show patterns linked to pneumonia, tuberculosis and other lung conditions.
- Computed Tomography (CT) scans, provide images and are particularly effective in detecting abscesses, complex infections and subtle lung changes that may not be visible on standard X rays.
- Magnetic Resonance Imaging (MRI) is ideal for imaging tissues. Is frequently employed to diagnose infections in the brain, spinal cord or other body parts. It is particularly useful in identifying abscesses, bone infections like osteomyelitis and certain parasitic infections.
- Ultrasound technology though reliant on operator skill offers the benefits of being radiation free and easily conducted at the patient’s bedside. It aids in guiding procedures such as abscess drainage. Can assist in diagnosing infections ranging from appendicitis to soft tissue issues.
- Nuclear medicine methods, like positron emission tomography (PET) combined with CT scans (PET/CT) can be quite useful in spotting infections or inflammation. These techniques involve using markers that gather in areas of metabolic activity often indicating infection sites.
7. New Advancements in Technology; Biosensors and Nanotechnology:
Among the promising areas are biosensors and nanotechnology driven approaches.
a. Biosensors, are devices used for analysis that combine an element with a chemical detector. In the realm of diseases biosensors can be tailored to identify pathogens or their components. For example, electrochemical biosensors can detect changes in properties when a target pathogen binds to a recognition element on the sensors surface.
b. Nanotechnology, is facilitating the creation of tools at the molecular level. Nanoparticles can be designed to interact with pathogens or host indicators of infection. For instance, gold nanoparticles can be modified with antibodies or nucleic acid probes to recognize pathogens often achieving sensitivity levels. They can swiftly conduct tests using minimal sample quantities, which makes them well suited for, on the spot testing.
8. Challenges and Future Paths, in Detecting Diseases:
Despite progress in diagnosing infectious diseases there are still various obstacles to overcome and the field is evolving rapidly. One persistent challenge lies in the demand for precise and easily accessible diagnostic tools especially in areas with limited resources where advanced laboratory facilities might be lacking.
Another major hurdle is posed by resistance (AMR). With pathogens adapting to resist existing treatments there’s a growing necessity for diagnostics that do not pinpoint the pathogen but also forecast its susceptibility to different antimicrobial agents.
The rise of pathogens, exemplified by the COVID 19 crisis, highlights the importance of diagnostic platforms that can swiftly adapt to identify emerging threats. Theres increasing interest in diagnostics of distinguishing between bacterial and viral infections to aid in judicious antibiotic use and combat AMR.
Looking ahead several developments are expected to influence infectious disease diagnostics. Intelligence and machine learning are progressively being harnessed to enhance test accuracy and analyse data from diverse origins. The fusion of diagnostics, with health technologies could facilitate real time disease monitoring and tailored patient care.
As our knowledge of the microbiome expands future diagnostic techniques may take an approach looking not only at the presence of pathogens but also at changes in the overall microbial community that could signal the presence of disease.
Disclaimer:
CBD:
Qrius does not provide medical advice.
The Narcotic Drugs and Psychotropic Substances Act, 1985 (NDPS Act) outlaws the recreational use of cannabis products in India. CBD oil, manufactured under a license issued by the Drugs and Cosmetics Act, 1940, can be legally used in India for medicinal purposes only with a prescription, subject to specific conditions. Kindly refer to the legalities here.
The information on this website is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or another qualified health provider with any questions regarding a medical condition or treatment. Never disregard professional medical advice or delay seeking it because of something you have read on this website.
Gambling:
As per the Public Gambling Act of 1867, all Indian states, except Goa, Daman, and Sikkim, prohibit gambling. Land-based casinos are legalized in Goa and Daman under the Goa, Daman and Diu Public Gambling Act 1976. In Sikkim, land-based casinos, online gambling, and e-gaming (games of chance) are legalized under the Sikkim Online Gaming (Regulation) Rules 2009. Only some Indian states have legalized online/regular lotteries, subject to state laws. Refer to the legalities here. Horse racing and betting on horse racing, including online betting, is permitted only in licensed premises in select states. Refer to the 1996 Supreme Court judgment for more information.
This article does not endorse or express the views of Qrius and/or its staff.
